FindTrial
Sign In

Efficacy in pachychoroid spectrum disorders patients treated with intravitreal aflibercept

Efficacy in pachychoroid spectrum disorders patients treated with intravitreal aflibercept

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048700
Enrollment
Unknown
Registered
2021-07-12
Start date
2020-11-15
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pachychoroid spectrum disorders

Interventions

IVA:Intravitreal Aflibercept
IVC:Intravitreal Conbercept

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with PCD. 2.No restrictions on gender or age. 3.Allow the use and disclosure of personal health information.

Exclusion criteria

Exclusion criteria: 1.Inflammation in the anterior segment. 2.Combined with other funds diseases. 3.Combined with systemic disease, such as Alzheimers disease, diabetes mellitus and cancer. 4.Patients cannot collaborate in the treatment.

Design outcomes

Primary

MeasureTime frame
best corrected visual ability;choroid thinkness;—

Countries

China

Contacts

Public ContactCai Qinhua

The First Affiliated Hospital of Soochow University

3173695856@qq.com+86 13182600826

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026